75 related articles for article (PubMed ID: 9336340)
1. Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse.
Kato A; Fukunari A; Sakai Y; Nakajima T
J Pharmacol Exp Ther; 1997 Oct; 283(1):328-35. PubMed ID: 9336340
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of prolyl endopeptidase and amyloid beta-peptide in brains of senescence-accelerated mouse.
Fukunari A; Kato A; Sakai Y; Yoshimoto T; Ishiura S; Suzuki K; Nakajima T
Neurosci Lett; 1994 Aug; 176(2):201-4. PubMed ID: 7830947
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical studies of age-associated amyloid deposition in the joint of senescence-accelerated mouse (SAM).
Shimizu K; Higuchi K; Matsushita M; Yamamuro T; Takeda T
Z Rheumatol; 1992; 51(5):243-8. PubMed ID: 1476009
[TBL] [Abstract][Full Text] [Related]
4. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging.
Iwata N; Takaki Y; Fukami S; Tsubuki S; Saido TC
J Neurosci Res; 2002 Nov; 70(3):493-500. PubMed ID: 12391610
[TBL] [Abstract][Full Text] [Related]
5. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936
[TBL] [Abstract][Full Text] [Related]
6. Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain.
Bellemère G; Vaudry H; Morain P; Jégou S
J Neuroendocrinol; 2005 May; 17(5):306-13. PubMed ID: 15869566
[TBL] [Abstract][Full Text] [Related]
7. Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse.
Takemura M; Nakamura S; Akiguchi I; Ueno M; Oka N; Ishikawa S; Shimada A; Kimura J; Takeda T
Am J Pathol; 1993 Jun; 142(6):1887-97. PubMed ID: 8506956
[TBL] [Abstract][Full Text] [Related]
8. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice.
Hooijmans CR; Graven C; Dederen PJ; Tanila H; van Groen T; Kiliaan AJ
Brain Res; 2007 Nov; 1181():93-103. PubMed ID: 17916337
[TBL] [Abstract][Full Text] [Related]
9. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus.
Zhao H; Li Q; Zhang Z; Pei X; Wang J; Li Y
Brain Res; 2009 Feb; 1256():111-22. PubMed ID: 19133247
[TBL] [Abstract][Full Text] [Related]
10. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
[TBL] [Abstract][Full Text] [Related]
11. Prolyl endopeptidase inhibitors from the leaves of Ginkgo biloba.
Lee JH; Lee SY; Lee KS; Jang HJ; Lee KH; Hahn TR; Paik YS
Planta Med; 2004 Dec; 70(12):1228-30. PubMed ID: 15643562
[TBL] [Abstract][Full Text] [Related]
12. Age-related accumulation of Reelin in amyloid-like deposits.
Knuesel I; Nyffeler M; Mormède C; Muhia M; Meyer U; Pietropaolo S; Yee BK; Pryce CR; LaFerla FM; Marighetto A; Feldon J
Neurobiol Aging; 2009 May; 30(5):697-716. PubMed ID: 17904250
[TBL] [Abstract][Full Text] [Related]
13. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
Schenk D; Barbour R; Dunn W; Gordon G; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Liao Z; Lieberburg I; Motter R; Mutter L; Soriano F; Shopp G; Vasquez N; Vandevert C; Walker S; Wogulis M; Yednock T; Games D; Seubert P
Nature; 1999 Jul; 400(6740):173-7. PubMed ID: 10408445
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
[TBL] [Abstract][Full Text] [Related]
15. Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs.
Zhang GR; Cheng XR; Zhou WX; Zhang YX
Neuroscience; 2009 Mar; 159(1):308-15. PubMed ID: 18721865
[TBL] [Abstract][Full Text] [Related]
16. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
17. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
18. Age-related expression of sigma1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse.
Phan VL; Miyamoto Y; Nabeshima T; Maurice T
J Neurosci Res; 2005 Feb; 79(4):561-72. PubMed ID: 15635598
[TBL] [Abstract][Full Text] [Related]
19. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.
Chen Q; Nakajima A; Choi SH; Xiong X; Tang YP
J Neurosci Res; 2008 May; 86(7):1615-25. PubMed ID: 18189321
[TBL] [Abstract][Full Text] [Related]
20. Sulfated chitooligosaccharides as prolyl endopeptidase inhibitor.
Je JY; Kim EK; Ahn CB; Moon SH; Jeon BT; Kim B; Park TK; Park PJ
Int J Biol Macromol; 2007 Dec; 41(5):529-33. PubMed ID: 17714777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
